HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Naturopath Marketing Brain Defense Supplement Anticipates Support For Making TBI Claims

Executive Summary

Cover Three Nutritional Brain Defense marketer agrees to pull claims suggesting the supplement beverage can protect against traumatic brain injury after a test the firm on DHA submitted as support contained considerably higher levels of the ingredient than included in the product.

You may also be interested in...



Rritual Superfoods' Market Entry Not Routine For Start-ups: CVS Placement, Rite Aid Merchandising

Rritual Superfoods distributes functional mushroom line in CVS and Rite Aid stores, targeting major markets including Boston, New York and San Diego. It plans to expand offerings in functional foods market forecast to reach $275bn by 2025.

CRN Ends Funding For Industry Self-Regulation Program Focused On Supplement Advertising

The trade group ends funding for National Advertising Division program launched in 2006 for increased focus on monitoring supplement claims, reviewing 360 in total. Separately, NAD launches an expedited challenge process aiming to conclude reviews in 20 business days.

Health And Wellness Market News: FTC Settlement, FDA Alert, UK Ad Reviews

FTC settles with operators of a bogus cognitive supplement sales ring for $26.2m; FDA warns on unapproved at-home head injury tests; and UK advertising regulator says HiSmile claims fail, P&G Always Discreet claims pass.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS150525

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel